Why the study?
13C labelled substrates are key to studying cardiac substrate use, but an accurate model is required to analyse complex data from their incorporation into the Krebs cycle.
A functional network model of Krebs cycle metabolism was successfully developed and validated ex vivo to quantitatively determine cardiac substrate metabolism.
Answers are grounded in this paper and cite their sources.
New model aids quantitative analysis of cardiac substrate oxidation; leaves open clinical validation before research or practice use.
Introduction Relative oxidation of different metabolic substrates in the heart varies both physiologically and pathologically, in order to meet metabolic demands under different circumstances. 13 C labelled substrates have become a key tool for studying substrate use—yet an accurate model is required to analyse the complex data produced as these substrates become incorporated into the Krebs cycle. Objectives We aimed to generate a network model for the quantitative analysis of Krebs cycle intermediate isotopologue distributions measured by mass spectrometry, to determine the 13 C labelled proportion of acetyl-CoA entering the Krebs cycle. Methods A model was generated, and validated ex vivo using isotopic distributions measured from isolated hearts perfused with buffer containing 11 mM glucose in total, with varying fractions of universally labelled with 13 C. The model was then employed to determine the relative oxidation of glucose and triacylglycerol by hearts perfused with 11 mM glucose and 0.4 mM equivalent Intralipid (a triacylglycerol mixture). Results The contribution of glucose to Krebs cycle oxidation was measured to be 79.1 ± 0.9%, independent of the fraction of buffer glucose which was U- 13 C labelled, or of which Krebs cycle intermediate was assessed. In the presence of Intralipid, glucose and triglyceride were determined to contribute 58 ± 3.6% and 35.6 ± 0.8% of acetyl-CoA entering the Krebs cycle, respectively. Conclusion These results demonstrate the accuracy of a functional model of Krebs cycle metabolism, which can allow quantitative determination of the effects of therapeutics and pathology on cardiac substrate metabolism.
No takes yet. Share an insight, caveat, or question.
Lindsay et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: